Filing Details
- Accession Number:
- 0001181431-11-023812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-04-13 16:09:01
- Reporting Period:
- 2011-04-11
- Filing Date:
- 2011-04-13
- Accepted Time:
- 2011-04-13 16:09:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1234564 | W Brian Metcalf | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | Chief Drug Discovery Scientist | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-04-11 | 100,000 | $5.46 | 166,504 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-04-11 | 50,000 | $17.40 | 116,504 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-04-11 | 50,000 | $17.42 | 66,504 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non Qualified Stock Option (right to buy) | Disposition | 2011-04-11 | 82,688 | $0.00 | 82,688 | $5.46 |
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2011-04-11 | 17,312 | $0.00 | 17,312 | $5.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-01-12 | No | 4 | M | Direct | |
0 | 2016-01-12 | No | 4 | M | Direct |
Footnotes
- Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.